Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Zimmer Holdings ( ZMH) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.3%. By the end of trading, Zimmer Holdings rose $1.09 (1.1%) to $98.25 on average volume. Throughout the day, 1,465,520 shares of Zimmer Holdings exchanged hands as compared to its average daily volume of 1,093,500 shares. The stock ranged in a price between $97.19-$98.87 after having opened the day at $97.20 as compared to the previous trading day's close of $97.16. Other companies within the Health Services industry that increased today were: Navidea Biopharmaceuticals ( NAVB), up 8.1%, SunLink Health Systems ( SSY), up 8.0%, Allied Healthcare Products ( AHPI), up 7.8% and Rosetta Genomics ( ROSG), up 6.6%.

Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. Zimmer Holdings has a market cap of $16.4 billion and is part of the health care sector. Shares are up 0.8% year to date as of the close of trading on Wednesday. Currently there are 10 analysts that rate Zimmer Holdings a buy, 1 analyst rates it a sell, and 11 rate it a hold.

TheStreet Ratings rates Zimmer Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity.

On the negative front, Biolase ( BIOL), down 9.3%, ERBA Diagnostics ( ERB), down 8.5%, WuXi PharmaTech (Cayman ( WX), down 8.2% and CAS Medical Systems ( CASM), down 6.5% , were all laggards within the health services industry with Universal Health Services ( UHS) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.